Filing Details

Accession Number:
0000096943-18-000070
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-04 19:34:28
Reporting Period:
2018-04-02
Accepted Time:
2018-04-04 19:34:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
96943 Teleflex Inc TFX Surgical & Medical Instruments & Apparatus (3841) 231147939
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1211667 Benson Smith 550 E. Swedesford Road
Suite 400
Wayne PA 19087
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-02 5,331 $57.78 83,711 No 4 M Direct
Common Stock Acquisiton 2018-04-02 2,000 $46.12 85,711 No 4 M Direct
Common Stock Acquisiton 2018-04-02 2,000 $61.34 87,711 No 4 M Direct
Common Stock Disposition 2018-04-02 3,231 $249.37 84,480 No 4 S Direct
Common Stock Disposition 2018-04-02 800 $250.12 83,680 No 4 S Direct
Common Stock Disposition 2018-04-02 2,600 $252.46 81,080 No 4 S Direct
Common Stock Disposition 2018-04-02 2,685 $253.50 78,395 No 4 S Direct
Common Stock Disposition 2018-04-02 15 $254.97 78,380 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option / (Right to Buy) Disposition 2018-04-02 5,331 $0.00 5,331 $57.78
Common Stock Stock Option / (Right to Buy) Disposition 2018-04-02 2,000 $0.00 2,000 $46.12
Common Stock Stock Option / (Right to Buy) Disposition 2018-04-02 2,000 $0.00 2,000 $61.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
102,642 2021-03-01 No 4 M Direct
0 2009-03-02 2019-03-02 No 4 M Direct
0 2010-03-01 2020-03-01 No 4 M Direct
Footnotes
  1. Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 13, 2018.
  2. This transaction was executed in multiple trades at prices ranging from $248.88 to $249.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $249.90 to $250.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $252.02 to $253.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $253.04 to $254.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. Exercisable for one-third of the shares on each of 3/1/2012, 3/1/2013 and 3/1/2014.